Johnson Financial Group Inc. Has $668,000 Position in The Allstate Co. (NYSE:ALL)

Johnson Financial Group Inc. reduced its holdings in shares of The Allstate Co. (NYSE:ALL) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,743 shares of the insurance provider’s stock after selling 567 shares during the period. Johnson Financial Group Inc.’s holdings in Allstate were worth $668,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in ALL. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Allstate during the 3rd quarter valued at about $25,000. Private Wealth Management Group LLC acquired a new stake in shares of Allstate during the 4th quarter valued at about $25,000. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Allstate during the 4th quarter valued at about $36,000. Venturi Wealth Management LLC boosted its position in shares of Allstate by 152.7% during the 4th quarter. Venturi Wealth Management LLC now owns 278 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 168 shares in the last quarter. Finally, Bruce G. Allen Investments LLC acquired a new position in Allstate in the fourth quarter valued at about $43,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Trading Up 0.5 %

Shares of ALL traded up $0.84 on Friday, reaching $164.84. 988,501 shares of the company’s stock were exchanged, compared to its average volume of 1,404,019. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $43.50 billion, a P/E ratio of 36.39, a price-to-earnings-growth ratio of 1.55 and a beta of 0.51. The business has a 50 day moving average price of $169.02 and a two-hundred day moving average price of $155.48. The Allstate Co. has a 12 month low of $100.57 and a 12 month high of $177.37.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share for the quarter, topping analysts’ consensus estimates of $4.11 by $1.02. The business had revenue of $15.26 billion during the quarter, compared to the consensus estimate of $12.76 billion. Allstate had a net margin of 2.31% and a return on equity of 14.44%. Allstate’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($1.30) earnings per share. Research analysts anticipate that The Allstate Co. will post 15.15 earnings per share for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, May 31st will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Friday, May 31st. Allstate’s payout ratio is presently 81.24%.

Insider Buying and Selling at Allstate

In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the sale, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on ALL. TheStreet upgraded shares of Allstate from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Roth Mkm boosted their price target on shares of Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Piper Sandler boosted their price target on shares of Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a research report on Monday, April 1st. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $185.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, May 2nd. Finally, StockNews.com upgraded shares of Allstate from a “buy” rating to a “strong-buy” rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $174.59.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.